Immediate Breast Reconstruction With Acellular Dermal Matrix

NCT ID: NCT04209010

Last Updated: 2020-01-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-01

Study Completion Date

2016-03-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to contribute to the knowledge regarding immediate implant-based BR by investigating whether the one-stage technique with ADM is superior to the two-stage expander to implant technique. Primary endpoint in first publication is postoperative complications, secondary endpoint is patient and investigator assessed aesthetic outcome. Primary endpoint in second publication is cost, secondary endpoint is patient reported outcome measures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Breast Carcinoma in Situ Mammaplasty Acellular Dermis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

One-stage group

Immediate implant based breast reconstruction after skin sparing mastectomy in one stage using silicone implant and acellular dermal matrix.

one-stage technique

Intervention Type PROCEDURE

breast reconstruction in one stage using silicone implant and acellular dermal matrix.

Two-stage group

Immediate implant based breast reconstruction after skin sparing mastectomy in two stages using expander to silicone implant technique.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

one-stage technique

breast reconstruction in one stage using silicone implant and acellular dermal matrix.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Skin sparing mastectomy due to breast cancer, ductal carcinoma in situ or high genetic risk of developing breast cancer
* Mastectomy weight ≤ 600 g
* Patient older than 18 years
* Ability to complete the study questionnaire
* Only for the two-stage group no later than 2 years and 4 months from breast reconstruction

Exclusion Criteria

\- smokers
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danish Cancer Society

OTHER

Sponsor Role collaborator

The Korning foundation

UNKNOWN

Sponsor Role collaborator

Foundation of the Kjaersgaard Family

UNKNOWN

Sponsor Role collaborator

King Christian X foundation

UNKNOWN

Sponsor Role collaborator

Foundation of architect Holger Hjortenberg

UNKNOWN

Sponsor Role collaborator

LifeCell Corporation (Branchburg, NJ, USA)

UNKNOWN

Sponsor Role collaborator

Aarhus University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mette Eline Brunbjerg, MD

MD, PhD student, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mette Eline Brunbjerg, MD

Role: PRINCIPAL_INVESTIGATOR

Aarhus University Hospital, Aarhus University, Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Brunbjerg ME, Jensen TB, Overgaard J, Christiansen P, Damsgaard TE. Comparison of one-stage direct-to-implant with acellular dermal matrix and two-stage immediate implant-based breast reconstruction-a cohort study. Gland Surg. 2021 Jan;10(1):207-218. doi: 10.21037/gs-20-581.

Reference Type DERIVED
PMID: 33633977 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VEK 1-10-72-572-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.